TRICIA CLAY: Open Payments
NPI 1407283153 · PLAINVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$649 in 6 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $92 · 2025 $649
Food & beverage: $649
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $243 |
| ABBVIE INC. | 2 | $185 |
| Otsuka America Pharmaceutical, Inc. | 1 | $123 |
| E.R. Squibb & Sons, L.L.C. | 1 | $98 |
Products named: CAPLYTA, VRAYLAR, REXULTI, COBENFY.
Industry payments across TX — which companies pay providers there.
